Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 2020; Volume 97,Issue 1

Commentary

  • You have access
    New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology
    Martin C. Michel, T.J. Murphy and Harvey J. Motulsky
    Molecular Pharmacology January 2020, 97 (1) 49-60; DOI: https://doi.org/10.1124/mol.119.118927

Articles

  • You have access
    Thyrotropin Causes Dose-dependent Biphasic Regulation of cAMP Production Mediated by Gs and Gi/o Proteins
    Susanne Neumann, Sarah S. Malik, Bernice Marcus-Samuels, Elena Eliseeva, Daesong Jang, Joanna Klubo-Gwiezdzinska, Christine C. Krieger and Marvin C. Gershengorn
    Molecular Pharmacology January 2020, 97 (1) 2-8; DOI: https://doi.org/10.1124/mol.119.117382
  • Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-<em>d</em>]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
    You have access
    Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
    Aamod S. Dekhne, Changwen Ning, Md. Junayed Nayeen, Khushbu Shah, Hasini Kalpage, Josephine Frühauf, Adrianne Wallace-Povirk, Carrie O’Connor, Zhanjun Hou, Seongho Kim, Maik Hüttemann, Aleem Gangjee and Larry H. Matherly
    Molecular Pharmacology January 2020, 97 (1) 9-22; DOI: https://doi.org/10.1124/mol.119.117937
  • You have access
    A NanoBRET-Based Binding Assay for Smoothened Allows Real-time Analysis of Ligand Binding and Distinction of Two Binding Sites for BODIPY-cyclopamine
    Paweł Kozielewicz, Carl-Fredrik Bowin, Ainoleena Turku and Gunnar Schulte
    Molecular Pharmacology January 2020, 97 (1) 23-34; DOI: https://doi.org/10.1124/mol.119.118158
  • You have access
    Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites
    Karen J. Gregory, Jesús Giraldo, Jiayin Diao, Arthur Christopoulos and Katie Leach
    Molecular Pharmacology January 2020, 97 (1) 35-47; DOI: https://doi.org/10.1124/mol.119.118091

Errata

  • You have access
    Correction to “Induction of CYP26A1 by Metabolites of Retinoic Acid: Evidence That CYP26A1 Is an Important Enzyme in the Elimination of Active Retinoids”
    Molecular Pharmacology January 2020, 97 (1) 1; DOI: https://doi.org/10.1124/mol.114.096784err
  • You have access
    Correction to “Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple orthosteric Binding Sites”
    Molecular Pharmacology January 2020, 97 (1) 48; DOI: https://doi.org/10.1124/mol.118.118091err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 97 (1)
Molecular Pharmacology
Vol. 97, Issue 1
1 Jan 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Commentary
  • Articles
  • Errata
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics